Regenxbio (RGNX) Current Taxes (2018 - 2022)

Regenxbio's Current Taxes history runs 5 years deep, the most recent figure standing at $12.7 million for Q1 2022.

• In Q1 2022, Current Taxes rose 216.4% year-over-year to $12.7 million; the TTM figure through Mar 2022 stood at $12.7 million (up 216.4% YoY), while the FY2021 annual figure was $11.3 million, up 261.24% from the prior year.
• Current Taxes was $12.7 million for Q1 2022 at Regenxbio, up from $11.3 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $12.7 million in Q1 2022 to a low of $508000.0 in Q3 2019.
• Historically, Current Taxes has averaged $3.8 million across 5 years, with a median of $1.8 million in 2018.
• The sharpest annual moves came in 2019 and 2021: Current Taxes sank 76.88% in 2019, then soared 261.24% in 2021.
• A 5-year view of Current Taxes shows it stood at $726000.0 in 2018, then tumbled by 30.03% to $508000.0 in 2019, then jumped by 517.13% to $3.1 million in 2020, then jumped by 261.24% to $11.3 million in 2021, then grew by 11.89% to $12.7 million in 2022.
• The last three Current Taxes figures came in at $12.7 million (Q1 2022), $11.3 million (Q4 2021), and $4.0 million (Q1 2021), per Business Quant data.